Wenjin Yin
No.160 Pujian Road
Shanghai, 200127, China
Shanghai, 200127, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Construction of a Lysine Lactylation- and DNA Damage Repair-Related Gene Signature to Predict the Prognosis and Drug Sensitivity of Breast Cancer Patients.
Journal: International journal of molecular sciences
Published: March 29, 2026
Development of a nursing-sensitive quality evaluation indicator system for perioperative care in breast reconstruction surgery: A Delphi study.
Journal: Asia-Pacific journal of oncology nursing
Published: October 27, 2025
Genetic variations in CYP2A6 predict efficacy of neoadjuvant letrozole concurrent with chemotherapy in locally advanced hormone receptor-positive breast cancer.
Journal: Annals of medicine
Published: September 17, 2025
Metronomic chemotherapy of paclitaxel plus cisplatin in patients with metastatic breast cancer: a target trial emulation study.
Journal: Therapeutic advances in medical oncology
Published: June 18, 2025
Cancer-associated adipocytes mediate CD8+T cell dysfunction via FGF21-driven lipolysis.
Journal: Cell reports
Published: April 21, 2025
Young-PEARL trial: paradoxical results of overall survival.
Journal: The Lancet. Oncology
Published: April 17, 2025
Dynamic Evolution of Vascular Features Based on Magnetic Resonance Imaging to Predict Pathological Response, Patterns of Recurrence and Survival Outcomes in Breast Cancer Neoadjuvant Chemotherapy.
Journal: Current oncology (Toronto, Ont.)
Published: March 29, 2025
SHCBP1 drives tumor progression in triple-negative breast cancer.
Journal: Frontiers in oncology
Published: March 04, 2025
EMC2 promotes triple negative breast cancer growth by protecting FDFT1 from endoplasmic reticulum associated degradation to impair ferroptosis susceptibility.
Journal: Oncogene
Published: January 06, 2025
Measurement of Intratumor Heterogeneity and Its Changing Pattern to Predict Response and Recurrence Risk After Neoadjuvant Chemotherapy in Breast Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: January 05, 2025
Stable or at least once HER2-low status during neoadjuvant chemotherapy confers survival benefit in patients with breast cancer.
Journal: Annals of medicine
Published: October 08, 2024
Last Updated: 09/26/2026